Company news

Certara, Inc. news in 2026

Certara, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Certara to Report Third Quarter 2026 Financial Results on November 5th, 2026

October 26, 2026

Certara Reports Second Quarter 2026 Financial Results

August 4, 2026

Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026

July 15, 2026

Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit

July 7, 2026

Certara Announces CFO Transition

June 17, 2026

Certara Reports First Quarter 2026 Financial Results

May 11, 2026

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development

May 7, 2026

Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat

April 22, 2026

Certara to Report First Quarter 2026 Financial Results on May 11th, 2026

April 9, 2026

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

March 2, 2026

Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance

February 25, 2026

Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025

January 29, 2026

Calls in 2026

Decks in 2026